No products in the cart.
Startseite » Suppliers » Dr. Paul Lohmann
Abstract Dextrin-based nanosponges (D-NS) are promising candidates for oral drug delivery due to their biocompatibility, mucoadhesive properties, and tunable swelling...
Abstract Alectinib (ALB) is a kinase inhibitor typically used for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer....
Abstract Lipid-based drug delivery carriers have exhibited substantial potential for promoting wound healing. Here, Phospholipon® 90H (P90H) based lipid nanoparticles...
Amino Acids are a crucial group of cell culture media ingredients Among many other, Tyrosine, Aspartic Acid and Glutamic Acid...
Our Mineral Salts in low endotoxin quality are produced under stringent GMP standards including low endotoxin process water. This unique...
Abstract The development of dry powder inhalers (DPIs) for pulmonary drug delivery is complex, requiring optimization of variable factors to...
Abstract Introduction/Objectives Compounded pimobendan is prescribed without knowledge of the effect of excipients. The objective of this study was to...
Abstract Much of the remarkable advancements in oral peptide delivery have been achieved through the use of chemical permeation enhancers,...
Abstract Oral administration of solid dosage forms for delivery of therapeutic peptides is highly desired. Preclinical investigations on co-administration with...
Abstract Polysaccharides and starch derivatives can play a role in the development of buccal film and patches. Buccal films are...
Copyright: PharmaExcipients AG